Zydus Cadila, first Indian Company gets permission for clinical trials of antibodies cocktail to treat COVID

The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been given permission to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO), according to sources.

from IndiaTV: Google News Feed https://ift.tt/3vQ1Xmd